Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFκB and ERK

PLoS One. 2015 Apr 24;10(4):e0125340. doi: 10.1371/journal.pone.0125340. eCollection 2015.

Abstract

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by abnormal autoreactivity in B cells. Lymphocytes and their soluble mediators contribute to the disease pathogenesis. We recently demonstrated that infecting lupus mice with malaria confers protection against lupus nephritis by attenuating oxidative stress in both liver and kidney tissues. In the current study, we further investigated B cell autoreactivity in female BWF1 lupus mice after infection with either live or gamma-irradiated malaria, using ELISA, flow cytometry and Western blot analysis. The lupus mice exhibited a significant elevation in plasma levels of IL-4, IL-6, IL-7, IL-12, IL-17, IFN-α, IFN-γ, TGF-β, BAFF and APRIL and a marked elevation of IgG2a, IgG3 and ant-dsDNA autoantibodies compared with normal healthy mice. Infecting lupus mice with live but not gamma-irradiated malaria parasite partially and significantly restored the levels of the soluble mediators that contribute to the progression of lupus. Furthermore, the B cells of lupus mice exhibited an increased proliferative capacity; aberrant overexpression of the chemokine receptor CXCR4; and a marked elevation in responsiveness to their cognate ligand (CXCL12) via aberrant activation of the PI3K/AKT, NFκB and ERK signaling pathways. Interestingly, infecting lupus mice with live but not gamma-irradiated malaria parasite restored a normal proliferative capacity, surface expression of CXCR4 and B cell response to CXCL-12. Taken together, our data present interesting findings that clarify, for the first time, the molecular mechanisms of how infection of lupus mice with malaria parasite controls B cell autoreactivity and thus confers protection against lupus severity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / immunology*
  • B-Cell Activating Factor / immunology
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / parasitology*
  • Cell Proliferation / physiology
  • Chemokine CXCL12 / immunology
  • Disease Models, Animal
  • Female
  • Immunoglobulin G / immunology
  • Interferon-alpha / immunology
  • Interferon-gamma / immunology
  • Interleukins / immunology
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / parasitology*
  • MAP Kinase Signaling System / immunology
  • Malaria / immunology
  • Mice
  • NF-kappa B / immunology
  • Parasites / immunology
  • Phosphatidylinositol 3-Kinases / immunology
  • Proto-Oncogene Proteins c-akt / immunology
  • Receptors, CXCR4 / immunology
  • Signal Transduction / immunology*
  • Tumor Necrosis Factor Ligand Superfamily Member 13 / immunology

Substances

  • Autoantibodies
  • B-Cell Activating Factor
  • CXCR4 protein, mouse
  • Chemokine CXCL12
  • Cxcl12 protein, mouse
  • Immunoglobulin G
  • Interferon-alpha
  • Interleukins
  • NF-kappa B
  • Receptors, CXCR4
  • Tnfsf13 protein, mouse
  • Tnfsf13b protein, mouse
  • Tumor Necrosis Factor Ligand Superfamily Member 13
  • Interferon-gamma
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt

Grants and funding

The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research group NO (RG -1435-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.